Clinical Trial Detail

NCT ID NCT01025089
Title Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

thymoma

thymic carcinoma

Therapies

Cetuximab

Cisplatin + Cyclophosphamide + Doxorubicin

Age Groups: adult

No variant requirements are available.